PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q1
- 저널
- JOURNAL OF OVARIAN RESEARCH12 · 2019
- 피인용
- Web of Science 32Scopus 37
- FWCI (Scopus)
- 2.23
- JCR IF
- JCR 2018 2.469
- ISSN
- 1757-2215
저자
- 김기형제1저자Department of Obstetrics and Gynecology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 최경운Department of Pathology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 김아롱Department of Pathology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 이소정Department of Pathology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 이정희Department of Pathology, Pusan National University Yangsan Hospital 20, Geumo-ro, Mulguem-eup Yangsan-si, Gyeongsangnam-do South Korea
- 서동수Department of Obstetrics and Gynecology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 권병수Department of Obstetrics and Gynecology, Pusan National University Hospital 179 Gudeok-ro, Seo-gu Busan 49241 South Korea
- 황청수교신저자Department of Pathology, Pusan National University Yangsan Hospital 20, Geumo-ro, Mulguem-eup Yangsan-si, Gyeongsangnam-do South Korea
초록
BackgroundPD-L1 expression levels determined by immunostaining are known to be related to the survival rate and prognosis of patients with various types of cancers, as well as to the therapeutic response to immune checkpoint inhibitors. Recently, the U.S. Food and Drug Administration approved an immune checkpoint inhibitor for the treatment of non-small cell lung cancer along with the clones used for PD-L1 immunostaining to predict the resulting response. In this study, we performed PD-L1 immunostaining of tissue microarrays from ovarian epithelial cancer using SP263, an approved clone, and examined the effect of PD-L1 expression on survival rate and prognosis.MethodsTissue microarrays were constructed from ovarian epithelial cancer tissues of 248 patients and PD-L1 immunostaining was performed using the SP263 clone. PD-L1 expression levels in tumor cells, intraepithelial tumor-infiltrating lymphocytes, and stromal tumor-infiltrating lymphocytes were evaluated, and the effect of PD-L1 expression on survival and prognosis was analyzed.ResultsPD-L1 was detected in tumor cells as well as intraepithelial tumor-infiltrating lymphocytes and stromal tumor-infiltrating lymphocytes. It was most frequently expressed in stromal tumor-infiltrating lymphocytes. The Kaplan-Meier curve analysis and log rank test showed that only high stromal PD-L1 expression was associated with increased overall survival in ovarian serous carcinoma. Multivariate and univariate Cox regression analyses revealed that stromal PD-L1 expression was an independent prognostic factor, especially in ovarian serous carcinoma.ConclusionsPD-L1 immunostaining using SP263 was observed in tumor cells as well as intraepithelial and stromal tumor-infiltrating lymphocytes. PD-L1-expressing stromal tumor-infiltrating lymphocytes were associated with an increased overall survival rate and may serve as a favorable prognostic factor in ovarian cancer, particularly serous carcinoma.
키워드
Ovarian cancerTumor-infiltrating lymphocytePD-L1SurvivalT-CELLSGRADEOVEREXPRESSIONIMPACT
식별자
- Scopus EID
- 2-s2.0-85067565632
- WoS UID
- 000471966600001



로그인
연구물 목록으로